Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Hyckel, Peter"'
Autor:
Hyckel, Peter1 (AUTHOR) peter.hyckel@web.de, Liehr, Thomas1 (AUTHOR) thomas.liehr@med.uni-jena.de
Publikováno v:
Journal of Clinical Medicine. Apr2024, Vol. 13 Issue 7, p2082. 11p.
Autor:
Schleier, Peter, Berndt, Alexander, Kolossa, Susann, Zenk, Witold, Hyckel, Peter, Schultze-Mosgau, Stefan
Publikováno v:
In Photodiagnosis and Photodynamic Therapy 2007 4(3):197-201
Autor:
Hyckel, Peter *, Berndt, Alexander, Schleier, Peter, Clement, Joachim H., Beensen, Volkmar, Peters, Hartmut, Kosmehl, Hartwig
Publikováno v:
In Journal of Cranio-Maxillofacial Surgery 2005 33(1):61-68
Autor:
Schlegel Karl A, Stockmann Phillip, Nkenke Emeka, Guentsch Arndt, Hyckel Peter, Wehrhan Falk, Neukam Friedrich W, Amann Kerstin
Publikováno v:
Journal of Translational Medicine, Vol 9, Iss 1, p 102 (2011)
Abstract Background Bisphosphonate associated osteonecrosis of the jaw (BRONJ) implies an impairment in oral hard- and soft tissue repair. An understanding of the signal transduction alterations involved can inform therapeutic strategies. Transformin
Externí odkaz:
https://doaj.org/article/53add15ceff84a05b8d08648e860fe04
Autor:
Schlegel Karl A, Nkenke Emeka, Stockmann Phillip, Ries Jutta, Hyckel Peter, Wehrhan Falk, Neukam Friedrich W, Amann Kerstin
Publikováno v:
Journal of Translational Medicine, Vol 8, Iss 1, p 96 (2010)
Abstract Background Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain th
Externí odkaz:
https://doaj.org/article/0bf0b6f6728444cf86c462a794dcfb4f
Autor:
Wehrhan, Falk1 Falk.Wehrhan@uk-erlangen.de, Hyckel, Peter2, Guentsch, Arndt3, Nkenke, Emeka1, Stockmann, Phillip1, Schlegel, Karl A.1, Neukam, Friedrich W.1, Amann, Kerstin4
Publikováno v:
Journal of Translational Medicine. 2011, Vol. 9 Issue 1, p102-112. 11p.
Autor:
Wehrhan, Falk1 Falk.Wehrhan@uk-erlangen.de, Hyckel, Peter2, Ries, Jutta1, Stockmann, Phillip1, Nkenke, Emeka1, Schlegel, Karl A.1, Neukam, Friedrich W.1, Amann, Kerstin3
Publikováno v:
Journal of Translational Medicine. 2010, Vol. 8, p96-104. 9p.
Autor:
Wehrhan, Falk, Hyckel, Peter, Amann, Kerstin, Ries, Jutta, Stockmann, Philipp, Schlegel, Karl Andreas, Neukam, Friedrich Wilhelm, Nkenke, Emeka
Publikováno v:
Oral Diseases
Oral Diseases, Wiley, 2011, 17 (4), pp.433. ⟨10.1111/j.1601-0825.2010.01778.x⟩
Oral Diseases, Wiley, 2011, 17 (4), pp.433. ⟨10.1111/j.1601-0825.2010.01778.x⟩
International audience; Objectives: Bone-destructive disease treatments include bisphosphonates and antibodies against RANKL (aRANKL). Osteonecrosis of the jaw (ONJ) is a side effect. Etiopathology models failed to explain their restriction to the ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e989990e2bffc4203741dd8b660a67db
https://hal.archives-ouvertes.fr/hal-00618503/file/PEER_stage2_10.1111%2Fj.1601-0825.2010.01778.x.pdf
https://hal.archives-ouvertes.fr/hal-00618503/file/PEER_stage2_10.1111%2Fj.1601-0825.2010.01778.x.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoe.
Publikováno v:
Cancer Immunology; 2015, p313-318, 6p